Publication | Closed Access

Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease

InflammationAutoimmune DiseaseT Cell DifferentiationT-regulatory CellImmunologyTreg Cell PhenotypeRegulatory T CellsAutoimmunityUlcerative ColitisImmunotherapyMedicineCell BiologyMouse Model